Intellia Therapeutics, Inc. (NTLA)
13.30
+0.17
(+1.29%)
USD |
NASDAQ |
Apr 06, 16:00
13.31
+0.01
(+0.08%)
After-Hours: 20:00
Intellia Therapeutics SG&A Expense (TTM) : 119.80M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 176.59M |
| Personalis, Inc. | 53.57M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Beam Therapeutics, Inc. | 113.82M |
| Pacific Biosciences of California, Inc. | 141.49M |